Researchers at the Hebrew
University of Jerusalem have uncovered new information about the abilities of
embryonic stem cells and their potential for future treatments. The study,
which shows the ability of embryonic stem cells to renew themselves
indefinitely, and differentiate into all types of mature cells, was conducted
by Dr. Eran Meshorer, head of the lab at the Department of Genetics at
HU's Alexander Silberman Institute of Life Sciences, and PhD student Shai
Melcer. It focused on epigenetic pathways that were specific to embryonic stem
cells, and chromatin.
SNIP
“This could
expedite the use of embryonic stem cells in cell therapy and regenerative
medicine, by enabling the creation of cells in the laboratory which could be
implanted in humans to cure diseases characterized by cell death, such as
Alzheimer's, Parkinson's, diabetes and other degenerative diseases.”
No comments:
Post a Comment